Subtractive single-chain antibody (Scfv) phagedisplay: Tailoring phage-display for high specificity against function-specific conformations of cell membrane molecules

Nature Protocols

Volumn 2, Issue 12, 2007, Pages 3063-3073

  Eisenhardt, Steffen U ^a   Schwarz, Meike ^b   Bassler, Nicole ^a   Peter, Karlheinz ^a  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE RECEPTOR; EPITOPE; IMMUNOGLOBULIN FRAGMENT; LIGAND; PEPTIDE LIBRARY;

ARTICLE; BACTERIOPHAGE M13; CHEMISTRY; IMMUNOGLOBULIN VARIABLE REGION; IMMUNOLOGY;

BACTERIOPHAGE M13; EPITOPES; IMMUNOGLOBULIN FRAGMENTS; IMMUNOGLOBULIN VARIABLE REGION; LIGANDS; PEPTIDE LIBRARY; RECEPTORS, CELL SURFACE;

EID: 38849132141     PISSN: 17542189     EISSN: 17502799     Source Type: Journal    
DOI: 10.1038/nprot.2007.455     Document Type: Article

References (28)

1. Clackson, T., Hoogenboom, H.R., Griffiths, A.D. & Winter, G. Making antibody fragments using phage display libraries. Nature 352, 624-628 (1991).
2. Giordano, R.J., Cardo-Vila, M., Lahdenranta, J., Pasqualini, R. & Arap, W. Biopanning and rapid analysis of selective interactive ligands. Nat. Med. 7, 1249-1253 (2001).
3. Arap, W. et al. Steps toward mapping the human vasculature by phage display. Nat. Med. 8, 121-127 (2002).
4. Schwarz, M. etal. Single-chain antibodies forthe conformation-specific blockade of activated platelet integrin alphaIIbbeta3 designed by subtractive selection from naive human phage libraries. FASEB J. 1704-1706 (2004).
5. Eisenhardt, S.U. etal. Generation of activation-specific human anti-alphaM/beta2 single-chain antibodies as potential diagnostic tools and therapeutic agents. Blood 109, 3521-3528 (2007).
6. Schwarz, M. et al. Conformation-specific blockade of the integrin GPIIb/IIIa: a novel antiplatelet strategy that selectively targets activated platelets. Circ. Res. 99, 25-33 (2006).
7. Fuchs, P., Breitling, F., Dubel, S., Seehaus, T. & Little, M. Targeting recombinant antibodies to the surface of Escherichia coli: fusion to a peptidoglycan associated lipoprotein. Biotechnology 9, 1369-1372 (1991).
8. Zahnd, C., Amstutz, P. & Pluckthun, A. Ribosome display: selecting and evolving proteins in vitro that specifically bind to a target. Nat. Methods 4, 269-279 (2007).
9. Roberts, R.W. & Szostak, J.W. RNA-peptide fusions for the in vitro selection of peptides and proteins. Proc. Natl. Acad. Sci. USA 94, 12297-12302 (1997).
10. Boder, E.T. & Wittrup, K.D. Yeast surface display for screening combinatorial polypeptide libraries. Nat. Biotechnol. 15, 553-557 (1997).
11. Smith, G.P. Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface. Science 228,1315-1317 (1985).
12. Barbas, C.F. III, Kang, A.S., Lerner, R.A. & Benkovic, S.J. Assembly of combinatorial antibody libraries on phage surfaces: the gene III site. Proc. Natl. Acad. Sci. USA 88, 7978-7982 (1991).
13. Hust, M., Maiss, E., Jacobsen, H.J. & Reinard, T. The production of a genus- specific recombinant antibody (scFv) using a recombinant potyvirus protease. J. Virol. Methods 106, 225-233 (2002).
14. Hawlisch, H. et al. Site-specific anti-C3a receptor single-chain antibodies selected by differential panning on cellulose sheets. Anal. Biochem. 293, 142-145 (2001).
15. Moghaddam, A. et al. Identification of scFv antibody fragments that specifically recognise the heroin metabolite 6-monoacetylmorphine but not morphine. J. Immunol. Methods 280, 139-155 (2003).
16. Robert, R. et al. Identification of human scFvs targeting atherosclerotic lesions: selection by single round in vivo phage display. J. Biol. Chem. 281, 40135-40143 (2006).
17. Little, M. et al. Generation of a large complex antibody library from multiple donors. J. Immunol. Methods 231, 3-9 (1999).
18. Dorsam, H. et al. Antibodies to steroids from a small human naive IgM library. FEBS Lett. 414, 7-13 (1997).
19. Takagi, J. & Springer, T.A. Integrin activation and structural rearrangement. Immunol. Rev. 186, 141-163 (2002).
20. Hynes, R.O. Integrins: versatility, modulation, and signaling in cell adhesion. Cell 69, 11-25 (1992).
21. Eisenhardt, S.U. etal. Generation of activation-specific human anti-alphaMbeta2 single-chain antibodies as potential diagnostic tools and therapeutic agents. Blood 109, 3521-3528 (2007).
22. Parsons, H.L. etal. Directing phage selections towards specific epitopes. Protein Eng. 9, 1043-1049 (1996).
23. Osbourn, J.K., Derbyshire, E.J., Vaughan, T.J., Field, A.W. & Johnson, K.S. Pathfinder selection: in situ isolation of novel antibodies. Immunotechnology 3, 293-302 (1998).
24. Osbourn, J.K. et al. Directed selection of MIP-1 alpha neutralizing CCR5 antibodies from a phage display human antibody library. Nat. Biotechnol. 16, 778-781 (1998).
25. Levitan, B. Stochastic modeling and optimization of phage display. J. Mol. Biol. 277, 893-916 (1998).
26. de Wildt, R.M., Mundy, C.R., Gorick, B.D. & Tomlinson, I.M. Antibody arrays for high-throughput screening of antibody-antigen interactions. Nat. Biotechnol. 18, 989-994 (2000).
27. Le Gall, F., Kipriyanov, S.M., Moldenhauer, G. & Little, M. Di-, tri- and tetrameric single chain Fv antibody fragments against human CD19: effect of valency on cell binding. FEBS Lett. 453,164-168 (1999).
28. Kipriyanov, S.M., Moldenhauer, G. & Little, M. High level production of soluble single chain antibodies in small-scale Escherichia coli cultures. J. Immunol. Methods 200, 69-77 (1997).